PRPO Stock Analysis: Buy, Sell, or Hold?
PRPO - Precipio, Inc. Common Stock
$24.40
-0.34 (-1.35%)
▼
5d:
-8.06%
30d:
-9.06%
90d:
+6.18%
HOLD
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 02, 2026
0d
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRPO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRPO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $24.40, which is considered oversold relative to its 30-day fair value range of $24.46 to $27.72.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $23.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $19.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $23.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $19.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$24.46 -
$27.72
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 23.2% above Wall St target ($19.00)
- CAUTION: Recommendation downgraded due to -8.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$24.46 -
$27.72
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$23.71
Resistance Level
$29.06
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-23.2%)
Revenue Growth (YoY)
27.3%
Profit Margin
-8.5%
Share & Embed Analysis
Last updated: April 02, 2026 1:44 PM ET
Data refreshes hourly during market hours. Next update: 2:44 PM
Data refreshes hourly during market hours. Next update: 2:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ahmed Zaki Sabet
BUY
20 shares
2026-01-02
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 67 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
